HSE enter 'final stages' of talks for Cystic Fibrosis drug Orkambi

The HSE will today enter the 'final stages' of talks to agree the price of a major new drug for Cystic Fibrosis.

HSE enter 'final stages' of talks for Cystic Fibrosis drug Orkambi

The HSE will today enter the 'final stages' of talks to agree the price of a major new drug for Cystic Fibrosis.

Senior management will spend the rest of the week in discussions with Vertex over the cost of the drug Orkambi.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited